title: Personalized medicine benefits patients in early trials: matching targeted therapies with gene mutations is associated with better outcomes, even in phase 1 studies.
authors.forename: Carrie
authors.initials: C
authors.lastname: Printz
mesh_terms: D017321:Clinical Trials, Phase I as Topic; D005820:Genetic Testing; D006801:Humans; D058990:Molecular Targeted Therapy; D009154:Mutation; D009369:Neoplasms / Q000188:drug therapy* / Q000235:genetics; D057285:Precision Medicine; D016896:Treatment Outcome